Investigating the relative efficacies of combination chemotherapy of paclitaxel/carboplatin, with or without anthracycline, for endometrial carcinoma

PURPOSE: Recently a combination of paclitaxel and carboplatin (TC) (without an anthracycline) has begun to be used as an adjuvant or remission induction therapy, without any critical supportive evidence of its efficacy relative to a combination chemotherapy of taxane, platinum and anthracycline such...

Descripción completa

Detalles Bibliográficos
Autores principales: Fujiwara, Kazuko, Egawa-Takata, Tomomi, Ueda, Yutaka, Kimura, Toshihiro, Yoshino, Kiyoshi, Fujita, Masami, Miyatake, Takashi, Ohta, Yukinobu, Kamiura, Shoji, Enomoto, Takayuki, Kimura, Tadashi
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer-Verlag 2011
Materias:
Gynecologic Oncology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3325403/
https://www.ncbi.nlm.nih.gov/pubmed/22127553
http://dx.doi.org/10.1007/s00404-011-2154-9

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3325403/
https://www.ncbi.nlm.nih.gov/pubmed/22127553
http://dx.doi.org/10.1007/s00404-011-2154-9

Ejemplares similares